Company intelligence / Profile preview

Vital

Toronto, Ontario, Canadavital.audio ↗

Ownership: Private
Development stage: Commercial

Overview

Vital Bio has developed the "VitalOne" diagnostic machine capable of performing over 50 routine blood tests at the point of care with results in about 20 minutes. The company has focused on ensuring high accuracy and transparency in its data and product demonstrations. As of mid/late 2023, the product had been publicly debuted but was not yet commercially launched.

Therapeutic areas: Other
Modalities: Device (point-of-care blood diagnostics)
Industry: Metabolite Diagnostics

Partnerships

Labcorp (investor/partner)

Beyond the preview

Go deeper on Vital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vital.

Explore the full profile